Care Pathways for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-The-Art Review - PubMed
3 hours ago
- #liver fibrosis
- #care pathway
- #MASLD
- MASLD is a growing clinical challenge requiring effective diagnostic strategies.
- Current guidelines recommend non-invasive tests (NITs) like FIB-4 and VCTE for patient stratification.
- Nine studies were reviewed, focusing on care pathways for detecting advanced fibrotic MASLD.
- Pathway populations included patients with type 2 diabetes or confirmed MASLD.
- Numbers needed to screen (NNS) varied widely across different pathways and populations.
- All studies reported improved patient risk stratification but noted declining attendance rates at each step.
- NIT-based care pathways can optimize transmural care for MASLD.
- Heterogeneity in pathway design calls for standardized protocols and larger validation studies.
- The review supports advancing MASLD management within evolving clinical frameworks.